PROS1 and COVID-19: While vaccines targeting the S protein has been shown to reduce COVID-19 morbidity and mortality [8], the intrinsic ability of SARS-CoV-2 to mutate quickly leads to generation of new viral strains with altered S protein that are capable of evading vaccine-induced immunity [9].